{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:13:17Z","timestamp":1785946397750,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq\/Brazil","doi-asserted-by":"publisher","award":["443150\/2014\u20131"],"award-info":[{"award-number":["443150\/2014\u20131"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["1871\u201325511\/13-4"],"award-info":[{"award-number":["1871\u201325511\/13-4"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.micpath.2020.104571","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T04:10:41Z","timestamp":1602821441000},"page":"104571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The antivirulence compound myricetin possesses remarkable synergistic effect with antibacterials upon multidrug resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4249-4558","authenticated-orcid":false,"given":"Helber Barboza","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Roberta","family":"Brust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Jos\u00e9","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8622-1052","authenticated-orcid":false,"given":"Danielle Silva","family":"Trentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2020.104571_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2020.104571_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2017.23","article-title":"Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance","volume":"16","author":"Dickey","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micpath.2020.104571_bib3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.33.7.991","article-title":"Methicilin-resistant staphylococci: genetics and mechanisms of resistance","volume":"33","author":"Hachbarth","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104571_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.meegid.2013.03.047","article-title":"The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA","volume":"21","author":"Howden","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2020.104571_bib5","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems","volume":"58","author":"Daikos","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104571_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0b013e3181e96b91","article-title":"A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic\/meta-regression study","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.micpath.2020.104571_bib7","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1469-0691.2010.03330.x","article-title":"Balancing the benefits and costs of antibiotic drugs: the treat model","volume":"16","author":"Leibovici","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2020.104571_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/21505594.2017.1325064","article-title":"Signatures of cytoplasmic proteins in the exoproteome distinguish community-and hospital-associated methicilin-resistant Staphylococcus aureus USA300 lineages","volume":"8","author":"Mekonnen","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2020.104571_bib9","first-page":"1","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"3099","author":"Tacconelli","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104571_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41589-019-0401-8","article-title":"Discovery of an antivirulence compound that reverses \u03b2-lactam resistance in MRSA","volume":"16","author":"El-halfawy","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.micpath.2020.104571_bib11","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1021\/acs.chemrev.6b00184","article-title":"Plant natural products targeting bacterial virulence factors","volume":"16","author":"Silva","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.micpath.2020.104571_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-02712-1","article-title":"Myricetin protects Galleria mellonella against Staphylococcus aureus infection and inhibits multiple virulence factors","volume":"7","author":"Silva","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2020.104571_bib13","first-page":"4","article-title":"The role of Staphylococcal carotenogenesis in resistance to host defense peptides and in vivo virulence in experimental endocarditis model","volume":"73","author":"Xiong","year":"2019","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.micpath.2020.104571_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/AAC.00680-10","article-title":"Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides","volume":"55","author":"Mishra","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104571_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2603435","article-title":"Impact of deficiencies in branched-chain fatty acids and staphyloxanthin in Staphylococcus aureus","author":"Braungardt","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2020.104571_bib16","doi-asserted-by":"crossref","first-page":"e00002","DOI":"10.1128\/IAI.00002-19","article-title":"MroQ Is a novel abi-domain protein that influences virulence gene expression in Staphylococcus aureus via modulation of agr activity","volume":"87","author":"Marroquin","year":"2019","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2020.104571_bib17","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.1153018","article-title":"A Cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence","author":"Liu","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.micpath.2020.104571_bib18","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cell.2017.10.012","article-title":"Membrane microdomain disassembly inhibits MRSA antibiotic resistance","volume":"171","author":"Garcia-Fern\u00e1ndez","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2020.104571_bib19","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2018"},{"key":"10.1016\/j.micpath.2020.104571_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jep.2011.05.030","article-title":"Potential of medicinal plants from the Brazilian semi-arid region (caatinga) against Staphylococcus epidermidis planktonic and biofilm lifestyles","volume":"137","author":"Trentin","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micpath.2020.104571_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: a strategy to extend the life of antibiotics in the 21st century","volume":"17","author":"Tyers","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2020.104571_bib22","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/AAC.43.7.1747","article-title":"Combinations of vancomycin and \u03b2-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin","volume":"43","author":"Climo","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104571_bib23","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104571_bib24","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/AAC.01232-08","article-title":"Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus","volume":"53","author":"Hughes","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104571_bib25","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1128\/AAC.02354-12","article-title":"Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus","volume":"57","author":"Werth","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104571_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/AAC.01204-13","article-title":"\u03b2-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone","volume":"58","author":"Dilworth","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104571_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00157-18","article-title":"\u03b2-Lactam combinations with vancomycin show synergistic activity against vancomycin-susceptible Staphylococcus aureus, vancomycin-intermediate S. aureus (VISA), and heterogeneous VISA","volume":"62","author":"Tran","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104571_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/civ808","article-title":"Combination of vancomycin and \u03b2-lactam therapy for methicilin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial","volume":"62","author":"Davis","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104571_bib29","series-title":"CAMERA2 Combination Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus Infection: Study Protocol for a Randomised Controlled Trial, Trials","first-page":"1","author":"Tong","year":"2016"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020309372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020309372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:43:26Z","timestamp":1760111006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401020309372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":29,"alternative-id":["S0882401020309372"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104571","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antivirulence compound myricetin possesses remarkable synergistic effect with antibacterials upon multidrug resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104571"}}